Recent FDA Actions on NSAIDS (June 2005)

Tags:
Recent, FDA, Actions, Nsaids, Vioxx, Rofecoxib, COX-2, Selective, Inhibitors, Bextra, Valdecoxib, Patient, Safety, Skin

Add video views to your Facebook Timeline:

On April 7, 2005, FDA announced several important changes that pertain to the marketing of non-steroidal anti-inflammatory drugs (NSAIDs). FDA has asked that one product be withdrawn from the market, and is requiring stronger warnings in the labeling for the other products. This is a continuation of the process that began several months ago with Vioxx (rofecoxib), when Merck withdrew that product from the market because of concerns about adverse cardiovascular events. These later actions are ...

  • Affiliate Submitter:
Powered by YouTube
  1. By: LawsuitGuru
  2. Categories Science & Tech
  3. Views 22
  4. Added :10-Jul-08
Comments on Recent FDA Actions on NSAIDS (June 2005)
Other comments on this video 0 Comments
 

Up Next: Binary Domain -- Exclusive Multiplayer Trailer